| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 06/16/2004 | CN1153580C Traditional Chinese medicine for treating lymph tuberculosis |
| 06/16/2004 | CN1153579C Buccal tablets for activating intelligent genes and increasing intelligence quotient |
| 06/16/2004 | CN1153572C Mineral salt composition and its use |
| 06/15/2004 | US6750251 Half-sandwich ruthenium (II) compounds comprising nitrogen containing ligands for treatment of cancer |
| 06/15/2004 | US6749870 Compositions and methods for the control of smoking |
| 06/15/2004 | US6749869 Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection |
| 06/10/2004 | WO2004048356A1 Inorganic ionic molecular crystal |
| 06/10/2004 | WO2004048287A1 Hardening bone compensate and remedy for skin defect using calcium phosphate sustainedly releasing zinc |
| 06/10/2004 | WO2004047765A2 Compositions, methods, and kits for weight loss and inhibiting the loss of lean body mass |
| 06/10/2004 | WO2004028461A3 Antiseptic solutions containing silver chelated with polypectate and edta |
| 06/10/2004 | WO2004006801A3 Treatment for dry eye syndrome |
| 06/10/2004 | WO2003087307A3 Use of interleukin-19 to treat cervical cancer |
| 06/10/2004 | US20040110837 use of therapeutic concentrations of an inhibitor of glycogen synthase kinase-3 (GSK-3) to block, reduce or inhibit processing of amyloid precursor proteins to beta-amyloid (A beta ) peptides which are believed to be the cause of Alzheimer's |
| 06/10/2004 | US20040110738 Administering silver- or metal compound as microbiocidal, anti-biofilm, bactericidal, antiinflammatory, fungicidal, viricidal and/or anticarcinogenic agent; skin disorders, dentistry |
| 06/10/2004 | US20040110719 Therapeutic use of methionine to reduce the toxicity of platinum-containing anti-tumor compounds |
| 06/10/2004 | US20040110662 Administering cytotoxic agent and heat shock protein 90 inhibitors such as ansamycins for synergistic growth inhibitors of cells. This therapy as cytotoxic agent and as cell growth inhibitors |
| 06/10/2004 | US20040109902 Dermatological formulations |
| 06/10/2004 | US20040109901 Compositions and methods for nutrition supplementation |
| 06/10/2004 | US20040109846 Restoring cancer-suppressing functions to neoplastic cells through DNA hypomethylation |
| 06/10/2004 | US20040108086 Using Ecteinascidin- 743 drug alone or as part of synergistic mixture |
| 06/09/2004 | EP1425582A1 Diagnostic markers for ischemia |
| 06/09/2004 | EP1425027A1 Method and composition for treatment of wounds and burns |
| 06/09/2004 | EP1424898A1 Treatment of cancers by inhalation of stable platinum-containing formulations |
| 06/09/2004 | EP1424889A2 Method for treating lung cancers |
| 06/09/2004 | CN1503668A Use of rare earth compounds for the prevention of kidney stone disease |
| 06/09/2004 | CN1503658A Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier |
| 06/09/2004 | CN1503632A Nutritional composition for immune condition |
| 06/09/2004 | CN1502584A Tourmalinite, medical stone ceramics |
| 06/09/2004 | CN1502344A Multi-function medicine for beautifying and treating scald by boiled water and fire and cold injury, and special container |
| 06/09/2004 | CN1502339A Rareearth beteropoly acid salt (blue) group anti-AIDS medicine and preparation process thereof |
| 06/09/2004 | CN1502338A Process for preparing red active nano elementary selengelatin microcapsule |
| 06/09/2004 | CN1502331A Anti-angiogenic compositions and methods of use |
| 06/09/2004 | CN1502326A Rectal suppository |
| 06/09/2004 | CN1152691C Use of chemically-stabilized chloride solution for inhibiting antigen-specific immune response |
| 06/08/2004 | US6747063 Augmenting actions of camp in an effector system while reducing camp action in a nociceptive system comprising application of one or more forms of nitrogen oxide or carbon monoxide to a site wherein camp exists |
| 06/08/2004 | US6747062 Adjusting concentration, blocking nitrogen oxide to damage tissue; nitric oxide synthase inhibitor |
| 06/08/2004 | US6747002 Determination, calibration erythropoietin dosage; analyzing using computer |
| 06/03/2004 | WO2004045680A1 Method for performing a photodynamic action on viruses or cells |
| 06/03/2004 | WO2004045679A1 Peritoneal dialysis method |
| 06/03/2004 | WO2004045655A2 Cleaning methods using chlorine dioxine solutions |
| 06/03/2004 | WO2004045654A2 Remediating of surfaces with embedded microbial contaminant |
| 06/03/2004 | WO2004045652A2 Biocompatible magnetic materials for the treatment of cancer by means of hyperthermia, and processes for their production |
| 06/03/2004 | WO2004045599A1 Therapeutic delivery of carbon monoxide |
| 06/03/2004 | WO2004045598A1 Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
| 06/03/2004 | WO2004045594A1 Agent for dissolving dental calculi and dental caries |
| 06/03/2004 | WO2004045551A2 Pharmaceutical composition |
| 06/03/2004 | US20040106185 Oral bacteriotherapy compositions and methods |
| 06/03/2004 | US20040105908 is excellent in safety and mineral absorption enhancing effects and is capable of alleviating mineral deficiency |
| 06/03/2004 | US20040105898 Acidified nitrite as an antimicrobial agent |
| 06/03/2004 | US20040105897 matrix metalloproteinases (MMPs) useful for treating chronic wounds |
| 06/03/2004 | US20040105896 Metal compunds, mixed or sulphated, as phosphate binders |
| 06/03/2004 | US20040105895 Monovalent-selective cation exchangers as oral sorbent therapy |
| 06/03/2004 | US20040105890 Biocompatible injectable materials |
| 06/03/2004 | US20040105848 Enteric dialysis to treat renal, kidney and gastrointestinal problems andprobiotic bacteria to reduce urea |
| 06/03/2004 | CA2506704A1 Peritoneal dialysis method |
| 06/02/2004 | EP1424076A1 Use of green coffee extract as mineral absorption enhancer |
| 06/02/2004 | EP1423131A1 Calcium salts with cytotoxic activity |
| 06/02/2004 | EP1423105A2 Combinations of dmxaa and other anti-cancer agents |
| 06/02/2004 | EP1423081A2 Composition comprising glycosaminogycans and hyaluronidase inhibitors for the treatment of arthritic joints |
| 06/02/2004 | EP1343865A4 Carrier for liquid ingredients to be used in effervescent products |
| 06/02/2004 | EP1123097B1 Pharmaceutical composition containing decursin |
| 06/02/2004 | EP0185759B2 Electrolyte solutions and (in vivo) use thereof |
| 06/02/2004 | CN2618510Y Health pillow for reducing blood pressure |
| 06/02/2004 | CN1501804A Acrochordon alleviation |
| 06/02/2004 | CN1500532A Product capable of emitting far infrared and method of using far infrared |
| 06/02/2004 | CN1500494A Compound formulation for myopia, hypermetropia, strabismus and amblyopia |
| 06/02/2004 | CN1151829C Medicine for treating lymphatic tuberculosis and lymphoma |
| 06/02/2004 | CN1151828C Medicine for treating bone fracture and preparation method |
| 06/02/2004 | CN1151827C Dressed plaster for treating facial palsy and its preparation |
| 06/02/2004 | CN1151820C Traditional Chinese medicine for treating rheumatic heart disease |
| 06/02/2004 | CN1151818C Diabetes treating traditional Chinese medicine |
| 06/02/2004 | CN1151815C Capsule for treating hepatic disease |
| 06/02/2004 | CN1151796C Remedy and preparation process of medicine for treating burns and scalds |
| 06/02/2004 | CN1151791C Sustained-release composition containing cefaclor |
| 06/02/2004 | CN1151776C Clear hydroalcoholic multivitamin solution containing physiologically effective amounts of beta-carotene |
| 06/01/2004 | US6743827 Method for preparing colloidal solution of bismuth sodium tartrate |
| 06/01/2004 | US6743824 Administering selegiline to patient in an amount sufficient to prevent, reduce or eliminate one or more of the symptoms associated with peripheral neuropathy |
| 06/01/2004 | US6743191 Hemofiltration; solution containing ions of dihydrogen phosphate, sodium, calcium, magnesium, potassium, acetate and chloride and glucose |
| 06/01/2004 | CA2295108C Method of enhancing magnesium absorption and prevention of atherosclerosis |
| 06/01/2004 | CA2196922C Pharmaceutically stable oxaliplatinum preparation |
| 05/27/2004 | WO2004044164A2 Method for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004044163A2 Methods for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004043481A2 Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto |
| 05/27/2004 | WO2004043473A1 Composition for restoring damaged skin |
| 05/27/2004 | WO2004043454A1 Acetyl-l-carnitine for the prevention and/or treatment of peripheral neuropathies induced by anticancer agents |
| 05/27/2004 | WO2004043451A1 Composition for the treatment of gastrointestinal disorders |
| 05/27/2004 | WO2004043393A2 Compositions for diabetes treatment and prophylaxis |
| 05/27/2004 | WO2004043357A2 Method of making, and the use of cytotoxic agents containing elemental selenium |
| 05/27/2004 | WO2004043341A2 Treatment for hemorrhagic shock |
| 05/27/2004 | WO2004043232A2 Methods for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004043147A1 Granulated cuprous oxide for antifouling coatings |
| 05/27/2004 | WO2004043146A2 Composition and method for mammary disinfection during winter conditions |
| 05/27/2004 | WO2004037311A3 Device and methods for sequential, regional delivery of multiple cytotoxic agents |
| 05/27/2004 | WO2003094902A3 Surface treatment of sars-infected lungs |
| 05/27/2004 | US20040101575 Comprehensive pharmacologic therapy for treatment of obesity |
| 05/27/2004 | US20040101573 Injectable composition for cancer treatment |
| 05/27/2004 | US20040101571 Use of hydrogen peroxide for the treatment of warts |
| 05/27/2004 | US20040101564 Embolization |
| 05/27/2004 | US20040101554 Fatty acid in soft gelatin capsule; plant and animal extracts; controlling taste |
| 05/27/2004 | US20040101553 Complex of liposome and platinum compound |